[go: up one dir, main page]

FR2621817B1 - DRUG COMPRISING POLYMYXIN B, TOBRAMYCIN AND AMPHOTERICIN B VAPORIZED - Google Patents

DRUG COMPRISING POLYMYXIN B, TOBRAMYCIN AND AMPHOTERICIN B VAPORIZED

Info

Publication number
FR2621817B1
FR2621817B1 FR8714345A FR8714345A FR2621817B1 FR 2621817 B1 FR2621817 B1 FR 2621817B1 FR 8714345 A FR8714345 A FR 8714345A FR 8714345 A FR8714345 A FR 8714345A FR 2621817 B1 FR2621817 B1 FR 2621817B1
Authority
FR
France
Prior art keywords
polymyxin
tobramycin
amphotericin
vaporized
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR8714345A
Other languages
French (fr)
Other versions
FR2621817A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medipro
Original Assignee
Medipro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medipro filed Critical Medipro
Priority to FR8714345A priority Critical patent/FR2621817B1/en
Priority to EP19880909559 priority patent/EP0338062A1/en
Priority to PCT/FR1988/000513 priority patent/WO1989003673A1/en
Priority to AU26140/88A priority patent/AU2614088A/en
Publication of FR2621817A1 publication Critical patent/FR2621817A1/en
Application granted granted Critical
Publication of FR2621817B1 publication Critical patent/FR2621817B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
FR8714345A 1987-10-19 1987-10-19 DRUG COMPRISING POLYMYXIN B, TOBRAMYCIN AND AMPHOTERICIN B VAPORIZED Expired - Lifetime FR2621817B1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR8714345A FR2621817B1 (en) 1987-10-19 1987-10-19 DRUG COMPRISING POLYMYXIN B, TOBRAMYCIN AND AMPHOTERICIN B VAPORIZED
EP19880909559 EP0338062A1 (en) 1987-10-19 1988-10-19 Drug comprising the association of polymyxin b, tobramycin and amphotericin b administered by spraying
PCT/FR1988/000513 WO1989003673A1 (en) 1987-10-19 1988-10-19 Drug comprising the association of polymyxin b, tobramycin and amphotericin b administered by spraying
AU26140/88A AU2614088A (en) 1987-10-19 1988-10-19 Drug comprising the association of polymyxin b, tobramycin and amphotericin b administered by spraying

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8714345A FR2621817B1 (en) 1987-10-19 1987-10-19 DRUG COMPRISING POLYMYXIN B, TOBRAMYCIN AND AMPHOTERICIN B VAPORIZED

Publications (2)

Publication Number Publication Date
FR2621817A1 FR2621817A1 (en) 1989-04-21
FR2621817B1 true FR2621817B1 (en) 1990-12-14

Family

ID=9355910

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8714345A Expired - Lifetime FR2621817B1 (en) 1987-10-19 1987-10-19 DRUG COMPRISING POLYMYXIN B, TOBRAMYCIN AND AMPHOTERICIN B VAPORIZED

Country Status (4)

Country Link
EP (1) EP0338062A1 (en)
AU (1) AU2614088A (en)
FR (1) FR2621817B1 (en)
WO (1) WO1989003673A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2290707A (en) * 1994-06-28 1996-01-10 Georgi Stankov Pharmaceutical uses of Amphotericin B
GB2290708A (en) * 1994-06-28 1996-01-10 Georgi Stankov Pharmaceutical uses of polyene macrolides
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
WO2010112358A2 (en) 2009-03-31 2010-10-07 Boehringer Ingelheim International Gmbh Method for coating a surface of a component
EP3508239B1 (en) 2009-05-18 2020-12-23 Boehringer Ingelheim International GmbH Adapter, inhalant apparatus and atomizer
AU2010323220B2 (en) 2009-11-25 2015-04-23 Boehringer Ingelheim International Gmbh Nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
WO2011064163A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
US9943654B2 (en) 2010-06-24 2018-04-17 Boehringer Ingelheim International Gmbh Nebulizer
EP2694220B1 (en) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medical device comprising a container
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (en) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Atomiser with coding means
ES2836977T3 (en) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizer
JP6643231B2 (en) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Nebulizer
US10722666B2 (en) 2014-05-07 2020-07-28 Boehringer Ingelheim International Gmbh Nebulizer with axially movable and lockable container and indicator
EP3139979B1 (en) 2014-05-07 2023-07-05 Boehringer Ingelheim International GmbH Unit, nebulizer and method
SG11201608891RA (en) 2014-05-07 2016-11-29 Boehringer Ingelheim Int Nebulizer, indicator device and container
WO2025137891A1 (en) * 2023-12-26 2025-07-03 苏州大学 Use of combined compound medicine in treating pathogenic bacteria persistent infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL121455C (en) * 1900-01-01
BE629985A (en) * 1962-11-29
AU539563B2 (en) * 1981-01-21 1984-10-04 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Primycin, doxycyline and sisomicin composition

Also Published As

Publication number Publication date
FR2621817A1 (en) 1989-04-21
WO1989003673A1 (en) 1989-05-05
AU2614088A (en) 1989-05-23
EP0338062A1 (en) 1989-10-25

Similar Documents

Publication Publication Date Title
FR2621817B1 (en) DRUG COMPRISING POLYMYXIN B, TOBRAMYCIN AND AMPHOTERICIN B VAPORIZED
FR2624015B1 (en) MEDICINE COMPRISING THE COMBINATION OF COLISTINE, TOBRAMYCIN AND AMPHOTERICIN B VAPORIZED
MX9203808A (en) HIGH DRUG CONTENT FORMULATIONS: LIPID, FROM LIPOSOMIC-ANTINEOPLASTIC AGENTS.
FR2621818B1 (en) MEDICINE COMPRISING THE COMBINATION OF POLYMIXIN B, NETILMICIN AND AMPHOTERICIN B BY VAPORIZATION
GR3017686T3 (en) Fluorocytidine derivatives, their preparation and medical preparations containing them.
GB2215986B (en) Disposable absorbent garments.
DE3880593D1 (en) MEDICINAL PREPARATIONS WITH RETARDED ACTIVE SUBSTANCE RELEASE.
FI943512L (en) Human serum albumin, preparation and use
DE3882157D1 (en) PHARMACEUTICAL PREPARATIONS CONTAINING NON-STEROX ANTI-IGNITION AGENTS.
FR2667317B1 (en) 2-AMINOPYRIMIDINE-4-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION.
ATA80390A (en) PHARMACEUTICAL PREPARATION WITH DELAYED ACTIVE SUBSTANCE RELEASE BASED ON HEMICELLULOSES
TR199903192T2 (en) Pharmaceutical combined preparations containing erythropoietin, modified hemoglobin.
DE69013557D1 (en) Bioactive compounds coupled to liposomes and their use in pharmaceutical preparations.
DE68902300D1 (en) PHARMACEUTICAL SOLUTION CONTAINING SALBUTAMOL AND CROMOGLYCIN ACID.
FR2718451B1 (en) Boronic peptide derivatives, their preparation and their therapeutic use.
AU7547787A (en) Dibenz(b,e)oxepin derivative and pharmaceutical containing the same as active ingredient
DE3867086D1 (en) BENZOTHIEPINO (5,4-C) PYRIDAZINE COMPOUNDS AND THEIR PHARMACEUTICAL EFFECTS.
NO892076D0 (en) DEVICE AT CHAIR.
NO168477C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CONDENSED DIAZEPINONES.
IL85869A0 (en) Milbemycin derivatives,their preparation and their use as parasiticides and insecticides
NO903939L (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CONDENSED DIAZEPINONES.
IT8721945A0 (en) PROCEDURE FOR THE FRAGRANCE OF BOOKS, DEVICE FOR THE IMPLEMENTATION OF SAID PROCEDURE
EP0489933A4 (en) Bile alcohol and drug containing the same as active ingredient
FR2697253B1 (en) 2-Aminopyrimidine-4-carboxamide derivatives, their preparation and their therapeutic use.
FR2694292B1 (en) Benzimidazole-2-thione- derivatives, their preparation and their use as medicaments.

Legal Events

Date Code Title Description
ST Notification of lapse